Impact of 4 different definitions used for the assessment of the prevalence of the metabolic syndrome in primary healthcare: The German metabolic and cardiovascular risk project (GEMCAS)

Cardiovascular Diabetology

Volumn 6, Issue , 2007, Pages

  Moebus, Susanne ^a   Hanisch, Jens ^a   Aidelsburger, Pamela ^b   Bramlage, Peter ^c   Wasem, Jürgen ^d   Jöckel, Karl Heinz ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b CAREM GmbH ^*  (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL ASSESSMENT; DEMOGRAPHY; DIABETES MELLITUS; DISEASE CLASSIFICATION; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIMARY HEALTH CARE; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; CLASSIFICATION; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; GERMANY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; FEMALE; GERMANY; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT;

EID: 35449005384     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-6-22     Document Type: Article

References (44)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486 11368702
2. Alberti KG Zimmet PZ Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 1998, 15:539-553. 10.1002/ (SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693
3. Grundy SM Brewer HB Cleeman JI Smith SC Lenfant C Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association. Circulation 2004, 109:433-438. 10.1161/01.CIR.0000111245.75752.C6 14744958
4. Grundy SM Cleeman JI Daniels SR Donato KA Eckel RH Franklin BA Gordon DJ Krauss RM Savage PJ Smith SC Jr. Spertus JA Costa F Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404 16157765
5. Federation ID The IDF consensus worldwide definition of the metabolic syndrom International Diabetes Federation www.idf.org 2005:1-14.
6. Alberti KG Zimmet P Shaw J IDF Epidemiology Task Force Consensus Group The metabolic syndrome - a new worldwide definition. Lancet 2005, 366:1059-1062. 10.1016/S0140-6736(05)67402-8 16182882
7. Li C Ford ES Definition of the Metabolic Syndrome: What's New and What Predicts Risk? Metabolic Syndrome and Related Disorders 2006, 4:237-251. 10.1089/met.2006.4.237
8. Moebus S Hanisch JU Neuhaeuser M Aidelsburger P Wasem J Joeckel KH Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: Feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices. GMS Ger Med Sci 2006, 4:DOc07, http://www.egms.de/en/gms/2006-4/000036.shtml.
9. Al Lawati JA Mohammed AJ Al Hinai HQ Jousilahti P Prevalence of the Metabolic Syndrome Among Omani Adults Diabetes Care 2003, 26:1781-1785. 10.2337/diacare.26.6.1781 12766109
10. Ford ES Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the U.S. Diabetes Care 2005, 28:2745-2749. 10.2337/diacare.28.11.2745 16249550
11. Athyros VG Bouloukos VI Pehlivanidis AN Papageorgiou AA Dionysopoulou SG Symeonidis AN Petridis DI Kapousouzi MI Satsoglou EA Mikhailidis DP The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study Diabetes, Obesity and Metabolism 2005, 7:397-405. 10.1111/j.1463-1326.2004.00409.x
12. Marques-Vidal P Mazoyer E Bongard V Gourdy P Ruidavets JB Drouet L Ferrieres J Prevalence of Insulin Resistance Syndrome in Southwestern France and Its Relationship With Inflammatory and Hemostatic Markers. Diabetes Care 2002, 25:1371-1377. 10.2337/diacare.25.8.1371 12145237
13. Azizi F Salehi P Etemadi A Zahedi-Asl S Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study Diabetes Res Clin Pract 2003, 61:29-37. 10.1016/S0168-8227(03)00066-4 12849921
14. Villegas R Perry IJ Creagh D Hinchion R O'Halloran D Prevalence of the metabolic syndrome in middle-aged men and women Diabetes Care 2003, 26:3198-3199. 10.2337/diacare.26.11.3198-a 14578275
15. Mancia G Bombelli M Corrao G Facchetti R Madotto F Giannattasio C Trevano FQ Grassi G Zanchetti A Sega R Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: Daily life blood pressure, cardiac damage, and prognosis Hypertension 2007, 49:40-47. 10.1161/01.HYP.0000251933.22091.24 17130308
16. Hillier TA Rousseau A Lange C Lepinay P Cailleau M Novak M Calliez E Ducimetiere P Balkau B Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis: The D.E.S.I.R. Cohort Diabetologia 2006, 49:1528-1535. 10.1007/ s00125-006-0266-8 16752171
17. Ko GT Cockram CS Chow CC Yeung V Chan WB So WY Chan NN Chan JC High prevalence of metabolic syndrome in Hong Kong Chinese - comparison of three diagnostic criteria. Diabetes Res Clin Pract 2005, 69:160-168. 10.1016/j.diabres.2004.11.015 16005365
18. Ford ES Giles WH Dietz WH Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey JAMA 2002, 287:356-359. 10.1001/jama.287.3.356 11790215
19. Ford ES Giles WH Mokdad AH Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004, 27:2444-2449. 10.2337/ diacare.27.10.2444 15451914
20. Lawlor DA Smith GD Ebrahim S Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study Diabetologia 2006, 49:41-48. 10.1007/s00125-005-0040-3 16378165
21. Jorgensen ME Bjerregaard P Gyntelberg F Borch-Johnsen K Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions. Diabetic Medicine 2004, 21:1237-1242. 10.1111/j.1464-5491.2004.01294.x 15498091
22. Lakka HM Laaksonen DE Lakka TA Niskanen LK Kumpusalo E Tuomilehto J Salonen JT The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 2002, 288:2709-2716. 10.1001/ jama.288.21.2709 12460094
23. Katzmarzyk PT Janssen I Ross R Church TS Blair SN The importance of waist circumference in the definition of metabolic syndrome: Prospective analyses of mortality in men Diabetes Care 2006, 29:404-409. 10.2337/ diacare.29.02.06.dc05-1636 16443895
24. Kim MH Kim MK Choi BY Shin YJ Educational disparities in the metabolic syndrome in a rapidly changing society-the case of South Korea. Int J of Epidemiology 2005, 34:1266-1273. 10.1093/ije/dyi175
25. Lorenzo C Serrano-Rios M Martinez-Larrad MT Gabriel R Williams K Gomez-Gerique JA Stern MP Haffner SM Central adiposity determines prevalence differences of the metabolic syndrome Obes Res 2003, 11:1480-1487. 14694212
26. Lee WY Park JS Noh SY Rhee EJ Kim SW Zimmet PZ Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects Diabetes Research and Clinical Practice 2004, 65:143-149. 10.1016/ j.diabres.2003.12.007
27. Sundstrom J Riserus U Byberg L Zethelius B Lithell H Lind L Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: Prospective, population based cohort study BMJ 2006, 332:878-882. 1440609 16510492 10.1136/bmj.38766.624097.1F
28. Gu D Reynolds K Wu X Chen J Duan X Reynolds RF Whelton PK He J Group IASIAC Prevalence of the metabolic syndrome and overweight among adults in China Lancet 2005, 365:1398-1405. 10.1016/S0140-6736(05)66375-1 15836888
29. Silventoinen K Pankow J Jousilahti P Hu G Tuomilehto J Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women Int J Epidemiol 2005, 34:327-334. 10.1093/ije/ dyi007 15659460
30. Isomaa B Almgren P Tuomi T Forsen B Lahti K Nissen M Taskinen MR Groop L Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 2001, 24:683-689. 10.2337/diacare.24.4.683 11315831
31. Hu G Qiao Q Tuomilehto J Balkau B Borch-Johnsen K Pyorala K Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women Arch Intern Med 2004, 164:1066-1076. 10.1001/archinte.164.10.1066 15159263
32. Group TDS Qiao Q Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006, V49:2837-2846. 10.1007/s00125-006-0438-6
33. Dekker JM Girman C Rhodes T Nijpels G Stehouwer CDA Bouter LM Heine RJ Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study Circulation 2005, 112:666-673. 10.1161/CIRCULATIONAHA.104.516948 16061755
34. Gupta A Gupta R Sarna M Rastogi S Gupta VP Kothari K Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract 2003, 61:69-76. 10.1016/ S0168-8227(03)00085-8 12849925
35. Abdul-Rahim HF Husseini A Bjertness E Giacaman R Gordon NH Jervell J The Metabolic Syndrome in the West Bank Population: An urban-rural comparison Diabetes Care 2001, 24:275-279. 10.2337/diacare.24.2.275 11213878
36. Balkau B Charles MA Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med 1999, 16:442-443. 10.1046/j.1464-5491.1999.00059.x 10342346
37. Jorgensen ME Borch-Johnsen K The metabolic syndrome -s one global definition possible? Diabet Med 2004, 21:1064-1065. 10.1111/ j.1464-5491.2004.01400.x 15384951
38. Franks PW Olsson T Metabolic Syndrome and Early Death: Getting to the Heart of the Problem. Hypertension 2007, 49:10-12. 10.1161/ 01.HYP.0000251934.55488.ae 17130307
39. Kohler E Ziese T Telefonischer Gesundheitssurvey des Robert Koch-Instituts zu chronischen Krankheiten und ihren Bedingungen. Berlin, Germany, Robert Koch-Institut,; 2004.
40. Pittrow D Bramlage P Hoefler M Kirch W Krause P Kuepper B Wittchen HU Praevalenz und Schweregrad von arterieller Hypertonie und Diabetes mellitus in der hausaerztlichen Praxis - ein unterschaetztes Problem. Journal für Hypertonie 2003, 7:7-11.
41. Tikhonoff V Casiglia E Metabolic syndrome: Nothing more than a constellation? Eur Heart J 2007, 28:780-781. 10.1093/eurheartj/ehm024 17400607
42. Kahn R Buse J Ferrannini E Stern M The metabolic syndrome Lancet 2005, 366:1921-1922. 10.1016/S0140-6736(05)67778-1 16325687
43. Athyros VG The Prevalence of the Metabolic Syndrome using the National Cholesterol Educational Program and International Diabetes Federation Definitions Curr Med Res opin 2005, 21:1157-1159. 10.1185/ 030079905X53333 16083523
44. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation 2002, 106:3143. 12485966